Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

HCL Tech to double headcount in smaller towns over next 2-3 years

The move comes amid the COVID-19 pandemic, as such locations fared better in tackling cases and also allows employees to move back to their hometowns – where they feel safer and be close to family

September 19, 2020 / 09:32 AM IST

HCL Technologies is planning to double headcount in smaller towns, including fresh hires and relocation of existing employees over a two-three year period, CEO C Vijayakumar said.

The smaller towns in focus include Lucknow, Madurai, Nagpur and Vijayawada and the company already has close to 10,000 employees working in these places, The Economic Times reported.

“Expansion will be a mix of both – some people will move from prime (locations) to New Vistas, and we will also hire freshers into the workforce,” he said.

Follow our LIVE Updates on the coronavirus pandemic here

The move comes amid the COVID-19 pandemic, Vijayakumar said, pointing out these locations fared better in tackling cases, while the decision also gives employees the leeway to move back to their hometowns – where they feel safer and be close to family.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

HCL has since 2016 opened centres, called New Vistas, in these small towns to create a more resilient global network, stabilise operations and control attrition.

Notably, 90 percent of HCL’s 4.3 million workforce in India has shifted to work-from-home since March and many have already migrated to their hometowns during the period.

Follow our full COVID-19 coverage here

Invite your friends and family to sign up for MC Tech 3, our daily newsletter that breaks down the biggest tech and startup stories of the day

Moneycontrol News
first published: Sep 19, 2020 09:32 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347